(Q57912114)

English

Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy (English)

0 references

0 references

1 reference

Roberto Ronca

2

0 references

Dario Neri

object named as

Dario Neri

series ordinal

8

0 references

author name string

Christina Ebbinghaus

series ordinal

1

0 references

Manuela Kaspar

series ordinal

3

0 references

Dragan Grabulovski

series ordinal

4

0 references

Alexander Berndt

series ordinal

5

0 references

Hartwig Kosmehl

series ordinal

6

0 references

Luciano Zardi

series ordinal

7

0 references

language of work or name

English

0 references

publication date

20 August 2005

0 references

published in

International Journal of Cancer

0 references

volume

116

0 references

issue

2

0 references

page(s)

304-313

0 references

cites work

An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.20952

retrieved

21 January 2018

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1074/JBC.M202069200

Identifiers

DOI

10.1002/IJC.20952

0 references

PubMed publication ID

15800913

0 references

(Q57912114)

Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)